CIK 0001621227 · Non-accelerated filer<br>Smaller reporting company
Adaptimmune Therapeutics PLC
Sign in to watch- Ticker
- ADAPY
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44 1235 430000
- Business address
- 60 JUBILEE AVENUE, MILTON PARK, ABINGDON, OXFORDSHIRE, United Kingdom
- Former names
- Adaptimmune Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-15 | Bertrand William C JR Chief Operating Officer | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | ||
| 2024-01-15 | Hege Kristen Director | Grant or award · Option to purchase Ordinary Shares | +81,906 | 81,906 | ||
| 2024-01-15 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +2,544,432 | 2,544,432 | ||
| 2024-01-15 | Lunger John Chief Patient Supply Officer | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | ||
| 2024-01-15 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +2,544,432 | 2,544,432 | ||
| 2024-01-15 | Brewer Joanna Elizabeth Chief Scientific Officer | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | ||
| 2024-01-15 | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | Grant or award · Option to purchase Ordinary Shares | +2,544,432 | 2,544,432 | ||
| 2024-01-15 | TAYTON-MARTIN HELEN KATRINA Chief Business & Strgy Officer | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | ||
| 2024-01-15 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +2,544,432 | 2,544,432 | ||
| 2024-01-15 | Wood Gavin Chief Financial Officer | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | ||
| 2024-01-15 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +2,544,432 | 2,544,432 | ||
| 2024-01-15 | Norry Elliot Chief Medical Officer | Grant or award · Option to purchase Ordinary Shares | +565,416 | 565,416 | ||
| 2024-01-15 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +7,633,296 | 7,633,296 | ||
| 2024-01-15 | Rawcliffe Adrian Chief Executive Officer | Grant or award · Option to purchase Ordinary Shares | +1,696,272 | 1,696,272 | ||
| 2024-01-12 | Bertrand William C JR Chief Operating Officer | Sale | −5,220 | $0.85 | $4K | 7,874 |
| 2024-01-12 | Lunger John Chief Patient Supply Officer | Sale | −5,220 | $0.85 | $4K | 7,874 |
| 2024-01-12 | Norry Elliot Chief Medical Officer | Sale | −7,799 | $0.85 | $7K | 11,841 |
| 2024-01-12 | Rawcliffe Adrian Chief Executive Officer | Sale | −17,257 | $0.85 | $15K | 26,388 |
| 2024-01-11 | Bertrand William C JR Chief Operating Officer | Sale | −4,009 | $0.84 | $3K | 6,104 |
| 2024-01-11 | Lunger John Chief Patient Supply Officer | Sale | −4,009 | $0.84 | $3K | 6,104 |
Page 4 of 23 · 454 trades